In conclusion, our study demonstrated that 12 weeks of PCA administration remarkably improved the endothelium-dependent vasorelaxation induced by insulin and IGF-1 in aging hypertension through enhancing the PI3K–NOS–NO pathway. The gene discussed is IGF1; the disease is Hypertension.